Sanofi has added another string to its Pompe disease therapy bow, after getting FDA approval for Nexviazyme, its latest therapy for the rare, inherited disorder. The US regulator has approved ...

LIC MF Infrastructure Fund (G) 11.33 1,33,930 1.13 LIC MF Infrastructure Fund - Direct (G) 11.33 1,33,930 1.13 LIC MF Infrastructure Fund - Direct (IDCW) 11.33 1 ...

Visit a quote page and your recently viewed tickers will be displayed here.

KSB Ltd. key Products/Revenue Segments include Pumps & Spares, Sale of services, Export Incentives and Scrap for the year ending 31-Dec-2023.For the quarter ended 31-03-2025, the company has reported ...

KSB Yearly Results: Get the key information of KSB Yearly results, previous Yearly Results, Yearly Earnings and comparison on Economic Times. Benchmarks Nifty 24,568.90 -147.7 ...